WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY) Morrisville, NC, USA & London, UK – December 1, 2023 – WEP Clinical (WEP), a [...]

WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED ACCESS PROTOCOL FOR IMETELSTAT Morrisville, NC, USA & London, UK – July 17, 2023 – WEP Clinical (WEP) is pleased to announce a partnership with [...]

WEP CLINICAL HAS PARTNERED WITH THERATECHNOLOGIES TO LAUNCH A NAMED PATIENT PROGRAM FOR EGRIFTA SV® Morrisville, NC, USA & London, UK – July 13, 2023 – WEP Clinical LTD (WEP), a specialist services company that [...]

WEP CLINICAL HAS PARTNERED WITH PHARMING GROUP TO SUPPLY LENIOLISIB POST-FDA APPROVAL THROUGH A POST-APPROVAL NAMED PATIENT PROGRAM Morrisville, NC, USA & London, UK – June 20, 2023 – WEP Clinical LTD (WEP), a specialist [...]

WEP CLINICAL PARTNERS WITH SOLASIA PHARMA K.K. TO LAUNCH DARVIAS NAMED PATIENT PROGRAM Morrisville, NC, USA & London, UK – March 20, 2023 – WEP Clinical LTD (WEP), a specialist services company that works with drug [...]

WEP CLINICAL PARTNERS WITH Y-MABS THERAPEUTICS TO PROVIDE DANYELZA THROUGH A NAMED PATIENT ACCESS PROGRAM IN EUROPE Morrisville, NC, USA & London, UK – February 16, 2023 – WEP Clinical (WEP) is pleased to announce [...]

WEP CLINICAL HAS PARTNERED WITH TAIMED BIOLOGICS TO LAUNCH A TROGARZO NAMED PATIENT PROGRAM Morrisville, NC, USA & London, UK – February 6, 2023 – WEP Clinical LTD (WEP), a specialist services company that works with [...]